Potential conflict of interest: Nothing to report.
Brief Communication
De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy†
Article first published online: 18 MAR 2009
DOI: 10.1002/ana.21625
Copyright © 2009 American Neurological Association
Additional Information
How to Cite
Hamdan, F. F., Piton, A., Gauthier, J., Lortie, A., Dubeau, F., Dobrzeniecka, S., Spiegelman, D., Noreau, A., Pellerin, S., Côté, M., Henrion, E., Fombonne, É., Mottron, L., Marineau, C., Drapeau, P., Lafrenière, R. G., Lacaille, J. C., Rouleau, G. A. and Michaud, J. L. (2009), De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy. Annals of Neurology, 65: 748–753. doi: 10.1002/ana.21625
- †
Publication History
- Issue published online: 25 JUN 2009
- Article first published online: 18 MAR 2009
- Accepted manuscript online: 18 MAR 2009 12:00AM EST
- Manuscript Accepted: 5 DEC 2008
- Manuscript Revised: 10 NOV 2008
- Manuscript Received: 26 SEP 2008
Funded by
- Canadian Institute of Health Research. Grant Number: GMH-79079
- Fonds de la Recherche en Santé (FRSQ)
- Genome Canada and Genome Quebec and Université de Montréal for the Synapse to Diseases (S2D) project
- Clinical Investigatorship Award of the Canadian Institute of Health Research (Institute of Genetics)
Abstract
We sequenced genes coding for components of the SNARE complex (STX1A, VAMP2, SNAP25) and their regulatory proteins (STXBP1/Munc18-1, SYT1), which are essential for neurotransmission, in 95 patients with idiopathic mental retardation. We identified de novo mutations in STXBP1 (nonsense, p.R388X; splicing, c.169+1G>A) in two patients with severe mental retardation and nonsyndromic epilepsy. Reverse transcriptase polymerase chain reaction and sequencing showed that the splicing mutation creates a stop codon downstream of exon-3. No de novo or deleterious mutations in STXBP1 were found in 190 control subjects, or in 142 autistic patients. These results suggest that STXBP1 disruption is associated with autosomal dominant mental retardation and nonsyndromic epilepsy. Ann Neurol 2009;65:748–753

1531-8249/asset/olbannerleft.gif?v=1&s=d36d5ebb3caa1b29d7f078a97c52973b0963daf2)
1531-8249/asset/olbannerright.gif?v=1&s=078041b213f6959d63575a593f880457c45116f0)
1531-8249/asset/cover.gif?v=1&s=685ec69724c5ed4c8847ce939e70ceb45065856f)